Anti-Idiotypic Agonistic Antibodies: Candidates for the Role of Universal Remedy
The COVID (Corona) Virus: WHAT WE HAVE TO KNOW!
Cytokine Storms: Understanding COVID-19
We thank Dr. So, et al1 for the interest in our letter2 and for sharing the results about the coronavirus disease 2019 (COVID-19) in patients with systemic lupus erythematosus (SLE) in Hong Kong1
Evidence of protective effect of hydroxychloroquine to prevent COVID-19
No SLE with COVID-19 in Hong Kong: the effect of masking?
Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials
The Plight of Patients with Lupus Nephritis during the Outbreak of COVID-19 in Wuhan, China
Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin
Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study